United Services Automobile Association’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-31,483
Closed -$2M 1422
2019
Q2
$2M Buy
31,483
+215
+0.7% +$13.7K 0.01% 1096
2019
Q1
$2.17M Buy
31,268
+1,047
+3% +$59.8K 0.01% 1066
2018
Q4
$1.31M Sell
30,221
-1,775
-6% -$97K ﹤0.01% 1157
2018
Q3
$2.44M Sell
31,996
-385
-1% -$31.3K 0.01% 1069
2018
Q2
$2.49M Sell
32,381
-671
-2% -$43.3K 0.01% 1068
2018
Q1
$1.69M Buy
33,052
+6,285
+23% +$317K ﹤0.01% 1177
2017
Q4
$1.24M Buy
26,767
+1,232
+5% +$60.4K ﹤0.01% 1175
2017
Q3
$1.36M Buy
25,535
+625
+3% +$37K ﹤0.01% 1143
2017
Q2
$1.55M Buy
24,910
+1,100
+5% +$66.3K ﹤0.01% 1099
2017
Q1
$1.61M Sell
23,810
-11,510
-33% -$877K 0.01% 1029
2016
Q4
$2.48M Buy
35,320
+890
+3% +$63.1K 0.01% 940
2016
Q3
$2.44M Sell
34,430
-80
-0.2% -$5.11K 0.01% 933
2016
Q2
$1.69M Sell
34,510
-970
-3% -$62.7K 0.01% 975
2016
Q1
$2.25M Buy
+35,480
New +$2.32M 0.01% 899

Other funds holding RARE

United Services Automobile Association's RARE Position: Q3 2019 in Review

United Services Automobile Association sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2019, closing a stake of 31,483 shares — an estimated $2M sold.

United Services Automobile Association first reported a position in RARE in Q1 2016 and held it in 14 quarters. The position peaked at $2.49M in Q2 2018. 172 funds tracked by Wall St. Rank hold RARE as of Q3 2019.

  • United Services Automobile Association reported no remaining Ultragenyx Pharmaceutical position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 31,483 Ultragenyx Pharmaceutical shares in Q3 2019, an estimated $2M.
  • United Services Automobile Association first reported a position in Ultragenyx Pharmaceutical in Q1 2016 and held it in 14 quarters.
  • United Services Automobile Association's Ultragenyx Pharmaceutical position peaked at $2.49M in Q2 2018.
  • 172 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.